Zhang Chunyan, Todorov Ivan, Lin Chia-Lei, Atkinson Mark, Kandeel Fouad, Forman Stephen, Zeng Defu
Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010, USA.
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2337-42. doi: 10.1073/pnas.0611101104. Epub 2007 Jan 31.
Type 1 diabetes in both humans and nonobese diabetic (NOD) mice results from autoreactive T cell destruction of insulin-producing beta cells. Cure of type 1 diabetes may require both reversal of autoimmunity and regeneration of beta cells. Induction of chimerism via allogeneic hematopoietic cell transplantation has been shown to reestablish tolerance in both prediabetic and diabetic NOD mice. However, it is unclear whether this therapy augments beta cell regeneration. Furthermore, this procedure usually requires total body irradiation conditioning of recipients. The toxicity of total body irradiation conditioning and potential for graft-versus-host disease (GVHD) limit the application of allogeneic hematopoietic cell transplantation for treating type 1 diabetes. Here we report that injection of donor bone marrow and CD4+ T cell-depleted spleen cells induced chimerism without causing GVHD in overtly diabetic NOD mice conditioned with anti-CD3/CD8 and that induction of chimerism in new-onset diabetic NOD mice led to elimination of insulitis, regeneration of host beta cells, and reversal of hyperglycemia. Therefore, this radiation-free GVHD preventive approach for induction of chimerism may represent a viable means for reversing type 1 diabetes.
人类和非肥胖糖尿病(NOD)小鼠的1型糖尿病是由自身反应性T细胞破坏产生胰岛素的β细胞所致。治愈1型糖尿病可能既需要逆转自身免疫,也需要β细胞再生。通过同种异体造血细胞移植诱导嵌合体已被证明可在糖尿病前期和糖尿病NOD小鼠中重建耐受性。然而,尚不清楚这种疗法是否能增强β细胞再生。此外,该程序通常需要对受体进行全身照射预处理。全身照射预处理的毒性和移植物抗宿主病(GVHD)的可能性限制了同种异体造血细胞移植在治疗1型糖尿病中的应用。在此,我们报告,在经抗CD3/CD8预处理的显性糖尿病NOD小鼠中,注射供体骨髓和去除CD4+T细胞的脾细胞可诱导嵌合体,且不会引起GVHD,并且在新发糖尿病NOD小鼠中诱导嵌合体可导致胰岛炎消除、宿主β细胞再生以及高血糖逆转。因此,这种用于诱导嵌合体的无辐射GVHD预防方法可能是逆转1型糖尿病的一种可行手段。